Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
42.03
+0.04 (0.10%)
At close: May 3, 2024, 4:00 PM
42.00
-0.03 (-0.07%)
After-hours: May 3, 2024, 6:00 PM EDT
Inari Medical Revenue
Inari Medical had revenue of $520.66M in the twelve months ending March 31, 2024, with 26.10% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $143.19M with 23.27% year-over-year growth. In the year 2023, Inari Medical had annual revenue of $493.63M with 28.73% growth.
Revenue (ttm)
$520.66M
Revenue Growth
+26.10%
P/S Ratio
4.69
Revenue / Employee
$400,507
Employees
1,300
Market Cap
2.44B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 493.63M | 110.16M | 28.73% |
Dec 31, 2022 | 383.47M | 106.49M | 38.45% |
Dec 31, 2021 | 276.98M | 137.31M | 98.31% |
Dec 31, 2020 | 139.67M | 88.54M | 173.17% |
Dec 31, 2019 | 51.13M | 44.30M | 648.70% |
Dec 31, 2018 | 6.83M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ICU Medical | 2.26B |
Premier | 1.32B |
Indivior | 1.12B |
LifeStance Health Group | 1.06B |
Tandem Diabetes Care | 770.01M |
Denali Therapeutics | 330.53M |
TG Therapeutics | 233.66M |
Rhythm Pharmaceuticals | 77.43M |
NARI News
- 2 days ago - ATTENTION NARI SHAREHOLDERS: Investors who Lost Money on Inari Medical, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - Accesswire
- 3 days ago - Levi & Korsinsky Investigates Possible Securities Fraud Violations by Inari Medical, Inc. (NARI) - Accesswire
- 5 days ago - Inari Medical Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 10 days ago - INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Inari Medical, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 16 days ago - NARI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Inari Medical, Inc. - Accesswire
- 16 days ago - Lost Money on Inari Medical, Inc.(NARI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - Accesswire
- 16 days ago - IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Inari Medical, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 17 days ago - Did Inari Medical, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - NARI - Accesswire